It is a healthcare public limited company based in Manimajra, Chandigarh, India, established in 1983.
1983 | Manimajra, Chandigarh, India | ActiveJapson Pharmaceuticals (Pb) Limited, a active public limited company, was established on 16 June 1983 in Manimajra, Chandigarh, India. Engaging in preventive health services within the hospital and medical care sector, it holds CIN: U56102CH1983PLC005474. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹8.00 M and a paid-up capital of ₹6.50 M.
It upholds a compliant status. Its leadership includes Angad Barnala Pratap (Director), Abhay Barnala (Director), Pervesh Bir (Director). Past directors included Majeed Najimudeen, Angad Barnala Pratap, Abhay Barnala. It holds ₹7.25 M open charges and ₹3.49 Cr settled loans. Its latest AGM occurred on 22 July 2024, with the balance sheet filed on 31 March 2024. It is based at 6328, Ground Floor, Rajiv Vihar,, Manimajra, Chandigarh, 160101.
U56102CH1983PLC005474
005474
16 June 1983
₹8.00 M
₹6.50 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Japson Pharmaceuticals (Pb) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Angad Barnala Pratap | Director | 03 May 2019 | Current |
| Abhay Barnala | Director | 03 May 2019 | Current |
| Pervesh Bir | Director | 15 Jan 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Apr 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 21 Jul 2024 | Past |
| Pramod Abcsdd | Nominee Director | 28 May 2019 | Past |
| Pramod Abcsdd | Managing Director | 15 Jan 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Japson Pharmaceuticals (Pb)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹7,250,000.00
₹34,850,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jan 1988 | State Bnak Of India | ₹1.45 M | Satisfied |
| 09 Jun 1987 | Panjab Financial Corporantion | ₹3.00 M | Satisfied |
| 12 Mar 1987 | Panjab State Industrial Development Corpo Ltd | ₹3.85 M | Satisfied |
| 02 Feb 1987 | State Bank Of India | ₹3.10 M | Satisfied |
| 26 Dec 1985 | State Bank Of India | ₹2.45 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Japson Pharmaceuticals (Pb), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Japson Pharmaceuticals (Pb), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Japson Pharmaceuticals (Pb)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Japson Pharmaceuticals (Pb) Limited last Annual general meeting of members was held on 22 Jul 2024 as per latest MCA records. was documented.
The activity Japson Pharmaceuticals (Pb) Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was completed.
Progress on Pervesh Bir was appointed as a Director was appointed as a Director on 15 Jan 2024 & has been associated with this company since 1 year 10 months . was documented.
Angad Barnala Pratap was appointed as a Director was appointed as a Director on 03 May 2019 & has been associated with this company since 6 years 6 months . was recorded as a recent event.
Abhay Barnala was appointed as a Director was appointed as a Director on 03 May 2019 & has been associated with this company since 6 years 6 months . was recorded as a recent event.
Progress on A charge registered on 09 Jun 1987 via Charge ID 90176446 with Panjab Financial Corporantion was fully satisfied on 12 Jun 2017. was documented.
The CIN of Japson Pharmaceuticals (Pb) Limited is U56102CH1983PLC005474.
Japson Pharmaceuticals (Pb) Limited is headquartered at 6328, Ground Floor, Rajiv Vihar,, Manimajra, Chandigarh, 160101.
Japson Pharmaceuticals (Pb) Limited was incorporated on 16 June 1983.
The current directors of Japson Pharmaceuticals (Pb) Limited are
The primary industry of Japson Pharmaceuticals (Pb) Limited is Hospital And Medical Care.
Japson Pharmaceuticals (Pb) Limited is unlisted.
The authorized capital of Japson Pharmaceuticals (Pb) Limited is ₹8.00 M, and the paid-up capital is ₹6.50 M.
The compliance status of Japson Pharmaceuticals (Pb) Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX